ArticleFrontiers in cardiovascular medicine2022

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study.

Wen-Yu Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.